Michael H. Veeder - Concepedia

Concepedia

Author

Michael H. Veeder

Also Known As

Michael H. Veeder, Michael Veeder

26

Publications

2.9K

Citations

16

H-Index

22

Concepts

All Affiliations

Mayo Clinic Iowa Oncology Research Association University of Nebraska Medical Center Mayo Clinic in Arizona Illinois CancerCare

MH

About

Michael H. Veeder is an author at Mayo Clinic specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	106
2	Health Sciences	2	2	41
3	Obstetrics	2	2	39
4	Pathology	1	1	16
5	Pharmacology	1	1	22

Michael H. Veeder

×

18

Publications

2.9K

Citations

16

H-Index

	Year	Citations
Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma Charles G. Moertel, Thomas R. Fleming, John S. Macdonald, New England Journal of Medicine	1990	2.2K
The role of radiotherapy in the management of operable locally advanced breast carcinoma John E. Olson, Donna Neuberg, Kishan J. Pandya, Cancer	1997	91
A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors David S. Hong, Drew Rasco, Michael H. Veeder, Oncology	2019	81
Phase III Clinical Trial of the Combination of Cisplatin, Dacarbazine, and Carmustine With or Without Tamoxifen in Patients With Advanced Malignant Melanoma Edward T. Creagan, Vera J. Suman, Robert J. Dalton, Journal of Clinical Oncology	1999	72
Long‐term results of the treatment of patients with mantle cell lymphoma with cladribine (2‐CDA) alone (95‐80‐53) or 2‐CDA and rituximab (N0189) in the North Central Cancer Treatment Group David J. Inwards, Paul A. S. Fishkin, David W. Hillman, Cancer	2008	66
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma James N. Ingle, Vera J. Suman, Carl G. Kardinal, Cancer	1999	62
A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma Richard M. Goldberg, Charles G. Moertel, H. Samuel Wieand, Cancer	1995	45
A Prospective Study of Pulmonary Function in Patients Receiving Mitomycin Mário Augusto Ferrari de Castro, Michael H. Veeder, James A. Mailliard, CHEST Journal Pulmonary CareAdvanced Lung DiseasePulmonary PhysiologyPulmonary FibrosisPulmonary Medicine	1996	42
A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma Michael H. Veeder, James R. Jett, John Q. Su, Cancer	1992	32
Phase II Study of Gemcitabine Plus Cisplatin in Patients With Metastatic Breast Cancer Patrick A. Burch, James A. Mailliard, David W. Hillman, American Journal of Clinical Oncology	2005	31

Page 1